During the past decade, Andrew Love Cancer Care Centre, Geelong Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Andrew Love Cancer Care Centre, Geelong Hospital" #1 sponsor was "Trans Tasman Radiation Oncology Group" with 12 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Barwon Health" with 1 trials sponsored, "Eucure (Beijing) Biopharma Co., Ltd" with 1 trials sponsored and "Royal Prince Alfred Hospital, Sydney, Australia" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Andrew Love Cancer Care Centre, Geelong Hospital" #1 collaborator was "Australasian Leukaemia and Lymphoma Group" with 3 trials as a collaborator, "National Health and Medical Research Council, Australia" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "The Royal Australian and New Zealand College of Radiologists" with 2 trials as a collaborator and "3M" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Andrew Love Cancer Care Centre, Geelong Hospital" are "Breast Cancer" (5 trials), "Prostate Cancer" (2 trials), "Adenocarcinoma of Rectum" (1 trials), "Anal Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Andrew Love Cancer Care Centre, Geelong Hospital" in a lesser frequency.

Most popular intervention types in "Andrew Love Cancer Care Centre, Geelong Hospital" are "Drug" (17 trials), "Radiation" (11 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Radiotherapy" (7 trials), "Docetaxel" (3 trials), "Pertuzumab" (3 trials), "5-Fluorouracil" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Andrew Love Cancer Care Centre, Geelong Hospital" are 16 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Andrew Love Cancer Care Centre, Geelong Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Andrew Love Cancer Care Centre, Geelong Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Andrew Love Cancer Care Centre, Geelong Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".